Xiang Zhu

Xiang Zhu

Auto-generated profile, based on publicly available information

Xiang Zhu

Department of Statistics, The Pennsylvania State University, University Park, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SGSarah E. Graham
Sarah E. Graham
SCShoa L. Clarke
Shoa L. Clarke
KWKuan-Han H. Wu
Kuan-Han H. Wu
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
GZGreg J. M. Zajac
Greg J. M. Zajac
CWCristen J. Willer
Cristen J. Willer

15 June 2020 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MVMarijana Vujkovic
Marijana Vujkovic
JKJacob M. Keaton
Jacob M. Keaton
JLJulie A Lynch
Julie A Lynch
DMDonald R. Miller
Donald R. Miller
JZJin Zhou
Jin Zhou
DSDanish Saleheen
Danish Saleheen
We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ancestry meta-analysis of 228,499 cases and 1,178,783 controls in the Million Veteran Program (MVP), DIAMANTE, Biobank Japan and other studies. We report 568 associations, including 286 autosomal, 7 X-chromosomal and 25 identified in ancestry-specific analyses that were previously unreported. Transcriptome-wide association analysis detected 3,568 T2D associations with genetically predicted gene expression in 687 novel genes; of these, 54 are known to interact with FDA-approved drugs. A polygenic risk score (PRS) was strongly associated with increased risk of T2D-related retinopathy and modestly associated with chronic kidney disease (CKD), peripheral artery disease (PAD) and neuropathy. We investigated the genetic etiology of T2D-related vascular outcomes in the MVP and observed statistical SNP–T2D interactions at 13 variants, including coronary heart disease (CHD), CKD, PAD and neuropathy. These findings may help to identify potential therapeutic targets for T2D and genomic pathways that link T2D to vascular outcomes.

1 August 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CTCatherine Tcheandjieu
Catherine Tcheandjieu
XZXiang Zhu
Xiang Zhu
AHAustin T. Hilliard
Austin T. Hilliard
SCShoa L. Clarke
Shoa L. Clarke
Valerio NapolioniValerio Napolioni
Valerio Napolioni
MPMillion Veteran Program
Million Veteran Program

2 June 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MVMarijana Vujkovic
Marijana Vujkovic
SRShweta Ramdas
Shweta Ramdas
KLKim M. Lorenz
Kim M. Lorenz
XGXiuqing Guo
Xiuqing Guo
RDRebecca Darlay
Rebecca Darlay
KCKyong-Mi Chang
Kyong-Mi Chang

2 September 2022 in Science
Verified
Journal Article
Closed access
XLXueqiu Lin
Xueqiu Lin
YLYanxia Liu
Yanxia Liu
SLShuai Liu
Shuai Liu
XZXiang Zhu
Xiang Zhu
LWLingling Wu
Lingling Wu
LQLei S. Qi
Lei S. Qi
Mammalian genomes have multiple enhancers spanning an ultralong distance (>megabases) to modulate important genes, but it is unclear how these enhancers coordinate to achieve this task. We combine multiplexed CRISPRi screening with machine learning to define quantitative enhancer-enhancer interactions. We find that the ultralong distance enhancer network has a nested multilayer architecture that confers functional robustness of gene expression. Experimental characterization reveals that enhancer epistasis is maintained by three-dimensional chromosomal interactions and BRD4 condensation. Machine learning prediction of synergistic enhancers provides an effective strategy to identify noncoding variant pairs associated with pathogenic genes in diseases beyond genome-wide association studies analysis. Our work unveils nested epistasis enhancer networks, which can better explain enhancer functions within cells and in diseases.

19 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXiang Zhu
Xiang Zhu
MSMatthew Stephens
Matthew Stephens
Genome-wide association studies (GWAS) aim to identify genetic factors associated with phenotypes. Standard analyses test variants for associations individually. However, variant-level associations are hard to identify and can be difficult to interpret biologically. Enrichment analyses help address both problems by targeting sets of biologically related variants. Here we introduce a new model-based enrichment method that requires only GWAS summary statistics. Applying this method to interrogate 4,026 gene sets in 31 human phenotypes identifies many previously-unreported enrichments, including enrichments of endochondral ossification pathway for height, NFAT-dependent transcription pathway for rheumatoid arthritis, brain-related genes for coronary artery disease, and liver-related genes for Alzheimer’s disease. A key feature of our method is that inferred enrichments automatically help identify new trait-associated genes. For example, accounting for enrichment in lipid transport genes highlights association between MTTP and low-density lipoprotein levels, whereas conventional analyses of the same data found no significant variants near this gene.